logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table INF-0. Bibliographic references

CountryReference NoReference
References for prevalence data
EU0no bibliographic reference is existing for this particular study
Belgium1Eurotox, Brussels (unpublished data).
Bulgaria1Tomov N. National Centre for Addictions.
Czech Republic1aNational Institute of Public Health, National Reference laboratory on AIDS, Prague, (unpublished data).
Denmark1aP.B. Christensen, H.B. Krarup, H.G.M. Niesters, H. Norder and J. Georgsen: Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol 2000; 16: 1043-1049.
Germany1IFT Institut for Therapy Research. EBIS-Report National Monitoring System for outpatient advisory and treatment facilities in Germany. Reference period 1.1. - 31.12.1999 IFT: Munich, Germany, no date.
Estonia1Kutsar K, Health Protection Inspectorate, Tallinn.
Ireland1Smyth, B., Keenan, E., O’Connor, JJ. (1998) Bloodborne viral infection in Irish injecting drug users. Addiction, 93 (11), 1649-56.
Greece1Greek REITOX Focal Point (EKTEPN), University Mental Health Research Institute (UMHRI).
Spain1Delegación del Gobierno para Plan Nacional Sobre Drogas (DGPNSD) Observatorio Español sobre Drogas (unpublished data).
Spain13De la Fuente L. Estudio sobre el cambio de vía de administración de la heroína en tres ciudades españolas (Madrid, Barcelona y Sevilla), unpublished data.
France1DREES (Direction de la recherhe, des études, de l’évaluation et des statistiques). (unpublished data).
Italy1aRilevazione Attività nel Settore Tossicodipendenze - Anno 2000, Ministero della Salute, Sistema Informativo Sanitario, Direzione Generale della Prevenzione, Ufficio Dipendenze da Farmaci e Sostanze d'Abuso e AIDS.
Cyprus1Infectious Diseases Indicator network, 2005. Minutes of the meetings held February 17 and March 9, 2005, unpublished,
Latvia1Sarmite S. Narcology Centre, Riga. (unpublished data)
Lithuania1Griškevicius A. Lietuvos AIDS centras, Vilnius, Lithuania. (unpublished data)
Luxembourg1aOriger A., Rapport national sur l'état de la situation du phénomène de la drogue - RELIS 2000, PFN, AST, Direction de la Santé, Luxembourg, 2000
Hungary1Csohán Á. National Center for Epidemiology, Department for Epidemiology, Budapest. (personal comm.)
Malta1SEDQA, Bimonthly Reports, 2003
Netherlands1Beuker RJ, Berns MPH, Rozendaal CM van, Snijders BM, Ameijden EJC van, Houweling H and Laar MJW van de. Surveillance of HIV-infection among injecting drug users in The Netherlands: results Amsterdam 1998. [in Dutch] Report 441100011. Rijksinstituut voor Volksgezondheid en Milieu (RIVM), Bilthoven, 2000.
Austria1Eigner R. Federal Ministry for Social Security and Generations, Special Register for Drug related Deaths (unpublished data).
Poland1Szata W. (2003) Aids i zakazenia HIV w roku 2001. Przegdad Epidemiologiczny, nr 1-2/2003.
Portugal1Centros de Atendimento a Toxicodependentes (CAT), Serviço de Prevenção e Tratamento da Toxicodependência (SPTT), Xabregas Lisbon, (unpublished data).
Romania1see International 2
Slovenia1Institute of Public Health of the Republic of Slovenia, Ljubljana.
Slovakia2Okruhlica, L. Surveillance of Drug Related Infectious Diseases in IDUs Utilizing Drug Treatment. EMCDDA EU expert meeting on drug related infectious diseases, Lisbon 20-21 October 2003. Meeting Report. EMCDDA 2004.
Finland1aHolmström P. National Public Health Institute (KTL) Department of Infectious Diseases Epidemiology (unpublished data).
Sweden1Kall, K., Thorstensson, R., Low HIV seroprevalence in spite of high-risk behaviour in nine Swedish prisons. 12th World AIDS Conference, Geneva, 1998. [abstract 23552].
United Kingdom1Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and hepatitis infections in the United Kingdom. London: Department of Health, 2000.
Croatia1Croatian Institute for Public Heatlh, Zagreb, 2008 (unpublished data)
Turkey1AMATEM Standart Data Collection System - Ministry of Helath - Annual Report
Norway1Konør H, MARIO – Methadone assisted rehabilitation in Oslo, unpublished data.
References for notifications data
International0no bibliographic reference is existing for this particular study
Bulgaria1Tomov N. National Centre for Addictions.
Czech Republic6Beneš, J. and Cástková, J. (2004) Viral Hepatits 1995 – 2003 – EPIDAT. Prague: National Institute of Public Health.)
Denmark4E. Smith. Statens Serum Institut.
Germany20Die Hepatitiden B und C bei drogenabhängigen Patienten: eine epidemiologische Studie. Suchttherapie, Supp. 2002; 3:51-52 / personal information
Estonia1Kutsar K, Health Protection Inspectorate, Tallinn.
Ireland13Smyth B, O'Connor JJ, Barry J, Keenan E. Retrospective cohort study examining incidence of HIV and Hepatitis C infection among injecting drug users in Dublin. Journal of Epidemiology and Community Health 2003;57:310-311.
France20Lucidarme D, Bruandet A, Ilef D, Harbonnier J, Jacob C, Decoster A, Delamare C, Cyran C, Van Hoenacker AF, Fremaux D, Josse P, Emmanuelli J, Le Strat Y, Desenclos JC, Filoche B.: Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France. Epidemiol Infect. 2004 Aug;132(4):699-708.
Italy28Istituto Superior di Sanità, Sistema epidemiologico integrata dell’epatite virale acuta (SEIEVA)
Latvia3Perevoscikovs J. State Public Health Agency. (Epidemiologijas biletens, Nr. 84 (720) June 16, 2003)
Lithuania4Bagdonaite J., Centre for Communicable Diseases Prevention and Control, Vilnius, Lithuania (unpublished data)
Luxembourg1dOriger A., Ministry of Health – Luxembourg
Hungary1Csohán Á. National Center for Epidemiology, Department for Epidemiology, Budapest. (personal comm.)
Malta42005 notifications to the Disease Surveillance Unit.
Netherlands19Op de Coul E., National Institute for Public Health and the Environment (RIVM), Bilthoven. (unpublished data).
Poland3National Focal Point, pers. comm. 2004.
Slovenia1Institute of Public Health of the Republic of Slovenia, Ljubljana.
Slovakia1Okruhlica, L., Klempova, D.: Hodnocení programu vakcinace proti hepatitide typu B u uživatelú drog v Bratislave (Evaluation of a Hepatitis B Vaccination Programme among Drug Users in Bratislava), Adiktologie, 2002, 2, p.11-18.
Finland1aHolmström P. National Public Health Institute (KTL) Department of Infectious Diseases Epidemiology (unpublished data).
Sweden3Swedish Institute for Infectious Disease Control
United Kingdom22Surveillance of known hepatitis C antibody cases in Scotland: Results to 30th June 2002. SCIEH Weekly Report 2003; 37(15): 96-101.
Norway4Marte Ødegård Lund, SIRUS – Norwegian Institute for Alcohol and Drug Research, unpublished data.

(see the help page for information about formats etc.)

Page last updated: Thursday, 20 January 2011